AbbVie Inc. (LON:0QCV)
London · Delayed Price · Currency is GBP · Price in USD 219.40
+1.60 (0.74%)
At close: Nov 7, 2025
AbbVie Market Cap
AbbVie has a market cap or net worth of 294.19 billion as of November 7, 2025. Its market cap has increased by 14.73% in one year.
Market Cap
294.19B
Enterprise Value
342.21B
Revenue
44.37B
Ranking
n/a
PE Ratio
168.42
Stock Price
219.40
Market Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 34.43B to 294.19B, an increase of 754.45%. That is a compound annual growth rate of 18.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 294.19B | 17.29% |
| Dec 31, 2024 | 250.83B | 16.77% |
| Dec 29, 2023 | 214.80B | -9.41% |
| Dec 30, 2022 | 237.12B | 34.13% |
| Dec 31, 2021 | 176.78B | 27.59% |
| Dec 31, 2020 | 138.56B | 40.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 70.92B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |